{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:10:03Z","timestamp":1763727003262,"version":"3.37.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,1,2]],"date-time":"2016-01-02T00:00:00Z","timestamp":1451692800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81330081; 81302784; 81302845; 31200675"],"award-info":[{"award-number":["81330081; 81302784; 81302845; 31200675"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013286","name":"Specialized Research Fund for the Doctoral Program of Higher Education","doi-asserted-by":"crossref","award":["20113420120006; 20123420110003"],"award-info":[{"award-number":["20113420120006; 20123420110003"]}],"id":[{"id":"10.13039\/501100013286","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Program for tackling key problems in science and technology by Anhui Province","award":["1301042098"],"award-info":[{"award-number":["1301042098"]}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province (CN)","doi-asserted-by":"publisher","award":["1408085QH173"],"award-info":[{"award-number":["1408085QH173"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Anhui Medical University Foundation","award":["2015xkj012"],"award-info":[{"award-number":["2015xkj012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s12026-015-8777-3","type":"journal-article","created":{"date-parts":[[2016,1,2]],"date-time":"2016-01-02T06:14:58Z","timestamp":1451715298000},"page":"978-987","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["hIgD promotes human Burkitt lymphoma Daudi cell proliferation by accelerated G1\/S transition via IgD receptor activity"],"prefix":"10.1007","volume":"64","author":[{"given":"Xing","family":"Dai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YuJing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiaoYi","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HuaXun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HengShi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WenSheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,2]]},"reference":[{"key":"8777_CR1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-9378-9-34","volume":"9","author":"G Pannone","year":"2014","unstructured":"Pannone G, Zamparese R, Pace M, Pedicillo MC, Cagiano S, Somma P, Errico ME, Donofrio V, Franco R, De Chiara A, Aquino G, Bucci P, Bucci E, Santoro A, Bufo P. The role of EBV in the pathogenesis of Burkitt\u2019s Lymphoma: an Italian hospital based survey. Infect Agent Cancer. 2014;9:34.","journal-title":"Infect Agent Cancer"},{"key":"8777_CR2","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0140-6736(11)61177-X","volume":"379","author":"EM Molyneux","year":"2012","unstructured":"Molyneux EM, Rochford R, Griffin B, Newton R, Jackson G, Menon G, Harrison CJ, Israels T, Bailey S. Burkitt\u2019s lymphoma. Lancet. 2012;379:1234\u201344.","journal-title":"Lancet"},{"key":"8777_CR3","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/onc.2009.377","volume":"29","author":"H Scheller","year":"2010","unstructured":"Scheller H, Tobollik S, Kutzera A, Eder M, Unterlehberg J, Pfeil I, Jungnickel B. c-myc overexpression promotes a germinal center-like program in Burkitt\u2019s lymphoma. Oncogene. 2010;29:888\u201397.","journal-title":"Oncogene"},{"key":"8777_CR4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0308-2261(82)80005-2","volume":"11","author":"H Stein","year":"1982","unstructured":"Stein H, Gerdes J, Mason DY. The normal and malignant germinal centre. Clin Haematol. 1982;11:531\u201359.","journal-title":"Clin Haematol"},{"key":"8777_CR5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/cncr.23522","volume":"113","author":"A Oriol","year":"2008","unstructured":"Oriol A, Ribera JM, Bergua J, Gim\u00e9nez Mesa E, Grande C, Esteve J, Brunet S, Moreno MJ, Escoda L, Hernandez-Rivas JM, Hoelzer D. High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients. Cancer. 2008;113:117\u201325.","journal-title":"Cancer"},{"key":"8777_CR6","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/QAD.0000000000000623","volume":"29","author":"F Alwan","year":"2015","unstructured":"Alwan F, He A, Montoto S, Kassam S, Mee M, Burns F, Edwards S, Wilson A, Tenant-Flowers M, Marcus R, Ardeshna KM, Bower M, Cwynarski K. Adding rituximab to CODOX-M\/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy. AIDS. 2015;29:903\u201310.","journal-title":"AIDS"},{"issue":"2","key":"8777_CR7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.imlet.2005.09.001","volume":"102","author":"R Geisberger","year":"2006","unstructured":"Geisberger R, K\u00f6nigsberger S, Achatz G. Membrane IgM influences membrane IgD mediated antigen internalization in the B cell line Bcl1. Immunol Lett. 2006;102(2):169\u201376.","journal-title":"Immunol Lett"},{"key":"8777_CR8","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3324\/haematol.2014.106054","volume":"99","author":"AC Bergh","year":"2014","unstructured":"Bergh AC, Evaldsson C, Pedersen LB, Geisler C, Stamatopoulos K, Rosenquist R, Ros\u00e9n A. Silenced B-cell receptor response to autoantigen in a poor-prognostic subset of chronic lymphocytic leukemia. Haematologica. 2014;99:1722\u201330.","journal-title":"Haematologica"},{"key":"8777_CR9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-1-4684-0922-2_7","volume":"8","author":"JW Goding","year":"1978","unstructured":"Goding JW. Allotypes of IgM and IgD receptors in the mouse: a probe for lymphocyte differentiation. Contemp Top Immunobiol. 1978;8:203\u201343.","journal-title":"Contemp Top Immunobiol"},{"key":"8777_CR10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4049\/jimmunol.136.1.83","volume":"136","author":"DF Jelinek","year":"1986","unstructured":"Jelinek DF, Splawski JB, Lipsky PE. Human peripheral blood B lymphocyte subpopulations: functional and phenotypic analysis of surface IgD positive and negative subsets. J Immunol. 1986;136:83\u201392.","journal-title":"J Immunol"},{"key":"8777_CR11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jaut.2010.03.003","volume":"35","author":"TG Nguyen","year":"2010","unstructured":"Nguyen TG, Little CB, Yenson VM, Jackson CJ, McCracken SA, Warning J, Stevens V, Gallery EG, Morris JM. Anti-IgD antibody attenuates collagen-induced arthritis by selectively depleting mature B-cells and promoting immune tolerance. J Autoimmun. 2010;35:86\u201397.","journal-title":"J Autoimmun"},{"key":"8777_CR12","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1365-3083.1974.tb01323.x","volume":"3","author":"JL Preud\u2019homme","year":"1974","unstructured":"Preud\u2019homme JL, Brouet JC, Clauvel JP, Seligmann M. Surface IgD in immunoproliferative disorders. Scand J Immunol. 1974;3:853\u20138.","journal-title":"Scand J Immunol"},{"key":"8777_CR13","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1002\/1097-0142(19800415)45:8<2084::AID-CNCR2820450815>3.0.CO;2-G","volume":"45","author":"PD Walzer","year":"1980","unstructured":"Walzer PD, Armstrong D, Weisman P, Tan C. Serum immunoglobulin levels in childhood Hodgkin\u2019s disease. Effect of splenectomy and long-term follow-up. Cancer. 1980;45:2084\u20139.","journal-title":"Cancer"},{"key":"8777_CR14","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1002\/ijc.24245","volume":"124","author":"RJ Biggar","year":"2009","unstructured":"Biggar RJ, Christiansen M, Rostgaard K, Smedby KE, Adami HO, Glimelius B, Hjalgrim H, Melbye M. Immunoglobulin subclass levels in patients with non-Hodgkin lymphoma. Int J Cancer. 2009;124:2616\u201320.","journal-title":"Int J Cancer"},{"key":"8777_CR15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/ard.57.4.255a","volume":"57","author":"N Brezniak","year":"1998","unstructured":"Brezniak N, Shtrasburg S, Langevitz P, Livneh A, Drenth JP, Shtrasburg S, Langevitz P. Serum IgD as a discriminator between the two periodic febrile syndromes hyperimmunoglobulinaemia D syndrome and Beh\u00e7et\u2019s disease. Ann Rheum Dis. 1998;57:255\u20136.","journal-title":"Ann Rheum Dis"},{"key":"8777_CR16","first-page":"211","volume":"10","author":"GT Kholmogorova","year":"1982","unstructured":"Kholmogorova GT, Stefani DV. Levels of IgD in patients with rheumatoid arthritis. Allergol Immunopathol (Madr). 1982;10:211\u20134.","journal-title":"Allergol Immunopathol (Madr)"},{"key":"8777_CR17","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.4049\/jimmunol.145.11.3556","volume":"145","author":"RF Coico","year":"1990","unstructured":"Coico RF, Tamma SL, Bessler M, Wei CF, Thorbecke GJ. IgD-receptor-positive human T lymphocytes. I. Modulation of receptor expression by oligomeric IgD and lymphokines. J Immunol. 1990;145:3556\u201361.","journal-title":"J Immunol"},{"key":"8777_CR18","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/316744a0","volume":"316","author":"RF Coico","year":"1985","unstructured":"Coico RF, Xue B, Wallace D, Pernis B, Siskind GW, Thorbecke GJ. T cells with receptors for IgD. Nature. 1985;316:744\u20136.","journal-title":"Nature"},{"key":"8777_CR19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1600-065X.1988.tb00765.x","volume":"105","author":"RF Coico","year":"1988","unstructured":"Coico RF, Siskind GW, Thorbecke GJ. Role of IgD and T delta cells in the regulation of the humoral immune response. Immunol Rev. 1988;105:45\u201367.","journal-title":"Immunol Rev"},{"key":"8777_CR20","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1006\/cimm.1993.1302","volume":"152","author":"AR Amin","year":"1993","unstructured":"Amin AR, Swenson CD, Xue B, Ishida Y, Nair BG, Patel TB, Chused TM, Thorbecke GJ. Regulation of IgD-receptor expression on murine T cells. II. Upregulation of IgD receptors is obtained after activation of various intracellular second-messenger systems; tyrosine kinase activity is required for the effect of IgD. Cell Immunol. 1993;152:422\u201339.","journal-title":"Cell Immunol"},{"key":"8777_CR21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1006\/cimm.2000.1747","volume":"207","author":"Y Wu","year":"2001","unstructured":"Lakshmi Tamma SM, Wu Y, Toporovsky I, Lima V, Coico RF. IgD receptor-mediated signal transduction in T cells. Cell Immunol. 2001;207:110\u20137.","journal-title":"Cell Immunol"},{"key":"8777_CR22","first-page":"579","volume":"50","author":"RA Rudders","year":"1982","unstructured":"Rudders RA, Andersen J. IgD-Fc receptors on normal and neoplastic human B lymphocytes. Clin Exp Immunol. 1982;50:579\u201386.","journal-title":"Clin Exp Immunol"},{"key":"8777_CR23","doi-asserted-by":"crossref","unstructured":"Lisanti MP, Sargiacomo M. Biotinylation and analysis of membrane-bound and soluble proteins. Curr Protoc Immunol. 2001;Chapter 8:Unit 8.16.","DOI":"10.1002\/0471142735.im0816s36"},{"key":"8777_CR24","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1398-9995.1991.tb04359.x","volume":"46","author":"Z Peng","year":"1991","unstructured":"Peng Z, Fisher R, Adkinson NF Jr. Total serum IgD is increased in atopic subjects. Allergy. 1991;46:436\u201344.","journal-title":"Allergy"},{"key":"8777_CR25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00281-015-0492-6","volume":"37","author":"CM Mulders-Manders","year":"2015","unstructured":"Mulders-Manders CM, Simon A. Hyper-IgD syndrome\/mevalonate kinase deficiency: what is new? Semin Immunopathol. 2015;37:371\u20136.","journal-title":"Semin Immunopathol"},{"key":"8777_CR26","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.4049\/jimmunol.166.3.1618","volume":"166","author":"GB Carey","year":"2001","unstructured":"Carey GB, Scott DW. Role of phosphatidylinositol 3-kinase in anti-IgM and anti-IgD-induced apoptosis in B cell lymphomas. J Immunol. 2001;166:1618\u201326.","journal-title":"J Immunol"},{"key":"8777_CR27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.leukres.2012.12.019","volume":"37","author":"S Tavolaro","year":"2013","unstructured":"Tavolaro S, Peragine N, Chiaretti S, Ricciardi MR, Raponi S, Messina M, Santangelo S, Marinelli M, Di Maio V, Mauro FR, Del Giudice I, Fo\u00e0 R, Guarini A. IgD cross-linking induces gene expression profiling changes and enhances apoptosis in chronic lymphocytic leukemia cells. Leuk Res. 2013;37:455\u201362.","journal-title":"Leuk Res"},{"key":"8777_CR28","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1006\/cimm.1998.1453","volume":"192","author":"Y Wu","year":"1999","unstructured":"Wu Y, Lakshmi Tamma SM, Lima V, Coico R. Facilitated antigen presentation by B cells expressing IgD when responding T cells express IgD-receptors. Cell Immunol. 1999;192:194\u2013202.","journal-title":"Cell Immunol"},{"key":"8777_CR29","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1182\/blood.V94.2.765","volume":"94","author":"M S\u00e1nchez-Beato","year":"1999","unstructured":"S\u00e1nchez-Beato M, Camacho FI, Mart\u00ednez-Montero JC, S\u00e1ez AI, Villuendas R, S\u00e1nchez-Verde L, Garc\u00eda JF, Piris MA. Anomalous high p27\/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27\/KIP1-cyclin D3 colocalization in tumor cells. Blood. 1999;94:765\u201372.","journal-title":"Blood"},{"key":"8777_CR30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9896(199806)185:2<159::AID-PATH73>3.0.CO;2-0","volume":"185","author":"C Doglioni","year":"1998","unstructured":"Doglioni C, Chiarelli C, Macr\u00ed E, Dei Tos AP, Meggiolaro E, Dalla Palma P, Barbareschi M. Cyclin D3 expression in normal, reactive and neoplastic tissues. J Pathol. 1998;185:159\u201366.","journal-title":"J Pathol"},{"key":"8777_CR31","first-page":"729","volume":"8","author":"M Filipits","year":"2002","unstructured":"Filipits M, Jaeger U, Pohl G, Stranzl T, Simonitsch I, Kaider A, Skrabs C, Pirker R. Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma. Clin Cancer Res. 2002;8:729\u201333.","journal-title":"Clin Cancer Res"},{"key":"8777_CR32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","volume":"490","author":"R Schmitz","year":"2012","unstructured":"Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, Liu X, Powell J, Yang Y, Xu W, Zhao H, Kohlhammer H, Rosenwald A, Kluin P, M\u00fcller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Ogwang MD, Reynolds SJ, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pittaluga S, Wilson W, Waldmann TA, Rowe M, Mbulaiteye SM, Rickinson AB, Staudt LM. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature. 2012;490:116\u201320.","journal-title":"Nature"},{"key":"8777_CR33","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1182\/blood.V91.5.1680","volume":"91","author":"U Klangby","year":"1998","unstructured":"Klangby U, Okan I, Magnusson KP, Wendland M, Lind P, Wiman KG. p16\/INK4a and p15\/INK4b gene methylation and absence of p16\/INK4a mRNA and protein expression in Burkitt\u2019s lymphoma. Blood. 1998;91:1680\u20137.","journal-title":"Blood"},{"key":"8777_CR34","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/path.4164","volume":"229","author":"H Guan","year":"2013","unstructured":"Guan H, Xie L, Klapproth K, Weitzer CD, Wirth T, Ushmorov A. Decitabine represses translocated MYC oncogene in Burkitt lymphoma. J Pathol. 2013;229:775\u201383.","journal-title":"J Pathol"},{"key":"8777_CR35","doi-asserted-by":"crossref","first-page":"e87182","DOI":"10.1371\/journal.pone.0087182","volume":"9","author":"GR Cavalheiro","year":"2014","unstructured":"Cavalheiro GR, Matos-Rodrigues GE, Gomes AL, Rodrigues PM, Martins RA. c-myc regulates cell proliferation during lens development. PLoS ONE. 2014;9:e87182.","journal-title":"PLoS ONE"},{"key":"8777_CR36","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4161\/trns.25907","volume":"4","author":"M Schuhmacher","year":"2013","unstructured":"Schuhmacher M, Eick D. Dose-dependent regulation of target gene expression and cell proliferation by c-myc levels. Transcription. 2013;4:192\u20137.","journal-title":"Transcription"},{"key":"8777_CR37","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0898-6568(95)00013-F","volume":"7","author":"L Jaso-Friedmann","year":"1995","unstructured":"Jaso-Friedmann L, Leary JH, Evans DL. Monoclonal antibody binding to a receptor on nonspecific cytotoxic cells (NCC) increases the expression of proto-oncogene kinases and protein kinase C. Cell Signal. 1995;7:463\u201370.","journal-title":"Cell Signal"},{"key":"8777_CR38","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.4049\/jimmunol.148.7.2050","volume":"148","author":"SM Tamma","year":"1992","unstructured":"Tamma SM, Coico RF. IgD-receptor-positive human T lymphocytes. II. Identification and partial characterization of human IgD-binding factor. J Immunol. 1992;148:2050\u20137.","journal-title":"J Immunol"},{"key":"8777_CR39","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1002\/eji.201141708","volume":"41","author":"AJ Gross","year":"2011","unstructured":"Gross AJ, Proekt I, DeFranco AL. Elevated BCR signaling and decreased survival of Lyn-deficient transitional and follicular B cells. Eur J Immunol. 2011;41:3645\u201355.","journal-title":"Eur J Immunol"},{"key":"8777_CR40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-065X.2008.00758.x","volume":"228","author":"P Scapini","year":"2009","unstructured":"Scapini P, Pereira S, Zhang H, Lowell CA. Multiple roles of Lyn kinase in myeloid cell signaling and function. Immunol Rev. 2009;228:23\u201340.","journal-title":"Immunol Rev"},{"key":"8777_CR41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1478-811X-10-21","volume":"10","author":"E Ingley","year":"2012","unstructured":"Ingley E. Functions of the Lyn tyrosine kinase in health and disease. Cell Commun Signal. 2012;10:21.","journal-title":"Cell Commun Signal"},{"key":"8777_CR42","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/MPA.0000000000000103","volume":"43","author":"DW Je","year":"2014","unstructured":"Je DW,\u00a0O YM, Ji YG, Cho Y, Lee DH. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion. Pancreas. 2014;43:768\u201376.","journal-title":"Pancreas"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-015-8777-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12026-015-8777-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-015-8777-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T10:30:48Z","timestamp":1692181848000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12026-015-8777-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,2]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["8777"],"URL":"https:\/\/doi.org\/10.1007\/s12026-015-8777-3","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"type":"print","value":"0257-277X"},{"type":"electronic","value":"1559-0755"}],"subject":[],"published":{"date-parts":[[2016,1,2]]}}}